Skip to content

WuXi PharmaTech (Cayman) Inc.

CIK 0001403132

Revenue (TTM)
FY Dec 2014
Net Income (TTM)
$112.16M
−2.1% YoY FY Dec 2014
EPS Diluted (TTM)
$0.19
−5.0% YoY FY Dec 2014
Gross Margin
FY Dec 2014
Operating Margin
FY Dec 2014
Net Margin
FY Dec 2014
Free Cash Flow (TTM)
$42.25M
FY Dec 2014
Cash
$211.46M
FY Dec 2014
Total Debt
$203.57M
FY Dec 2014
Shares Outstanding
561.16M sh
FY Dec 2014

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings